Confluent Investor Presentation Deck

GAAP to Non-GAAP Reconciliations (in thousands, except percentages) Total revenue Research and development (R&D) expense on a GAAP basis Less: Stock-based compensation expense Less: Employer taxes on employee stock transactions Less: Acquisition-related expenses Non-GAAP R&D expense Non-GAAP R&D expense as a % of total revenue Total revenue Sales and marketing (S&M) expense on a GAAP basis Less: Stock-based compensation expense Less: Employer taxes on employee stock transactions Less: Acquisition-related expenses Non-GAAP S&M expense Non-GAAP S&M expense as a % of total revenue FY'21 $387,864 $161,925 49,051 2,278 $110,596 28.5% FY'21 $387,864 $319,331 55,506 4,266 $259,559 66.9% FY'22 $585,944 $264,041 101,499 2,632 $159,910 27.3% FY'22 $585,944 $456,452 99,366 2,485 $354,601 60.5% Q2'22 $139,407 $64,472 25,337 342 $38,793 27.8% Q2'22 $139,407 $112,754 24,746 1,048 $86,960 62.4% Q2'23 $189,285 $85,677 35,420 1,306 3,841 $45,110 23.8% Q2'23 $189,285 $127,770 32,889 1,488 1,076 $92,317 48.8% 54

View entire presentation